Intermediate Dose of IV MTX as CNS Prophylaxis for High Risk DLBCL
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Diffuse Large B Cell Lymphoma
Related studies linked through entity extraction aliases.
Imaging Apoptosis for Lymphoma Treatment Response
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden
- Status
- RECRUITING
- Phase
- NA
Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With DLBCL in Low Risk
- Status
- RECRUITING
- Phase
- PHASE3
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study for Late Assessment of the Safety and Efficacy of Biosimilar Rituximab
- Status
- COMPLETED
- Phase
- N/A
A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Immune Responses to COVID-19 Vaccination in Lymphoma Patients
- Status
- COMPLETED
- Phase
- N/A
Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
CD19-targeted CAR T Cells （JWCAR029） for Primary Refractory Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Secondary Prognostic Index in RefrActory Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
- Status
- RECRUITING
- Phase
- PHASE1
First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Study of ADI-001 in B Cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
RadiothErapy priMIng for CAR-T
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Observational Retrospective Cohort Study of Systemic Therapies for R/R DLBCL
- Status
- COMPLETED
- Phase
- N/A